CJC-1295 No DAC 2mg: What Researchers Need to Know

CJC-1295 no DAC 2mg refers to a 2-milligram vial of lyophilized CJC-1295 that lacks the Drug Affinity Complex (DAC). It is a modified growth hormone-releasing hormone (GHRH) analog, often labeled mod GRF 1-29, and it is sold strictly for laboratory research rather than human use. Because the DAC tail is removed, the peptide clears the body far faster than the DAC version and produces shorter, more pulsatile growth hormone signals in research models.

What Makes CJC-1295 No DAC Different

CJC-1295 is a synthetic analog of GHRH engineered to resist enzymatic breakdown in the bloodstream. The no-DAC version, also written as cjc-1295 no dac; mod grf 1-29, keeps the receptor-binding sequence but drops the albumin-binding tail.

Key characteristics of the compound:

• Synthetic 29-amino-acid GHRH analog
• Half-life in published research is roughly 30 minutes
• Usually supplied as a white lyophilized powder in 2mg, 5mg, or 10mg vials
• Requires reconstitution with bacteriostatic water before use
• Banned by WADA and not FDA-approved for human use

CJC-1295 DAC vs No DAC: How They Compare

The main difference between the two versions comes down to a single chemical modification. DAC stands for Drug Affinity Complex, a maleimide group that tethers the peptide to serum albumin.

That tether is what stretches the half-life from minutes to roughly a week. The table below answers the question researchers ask most often when they compare cjc-1295 dac vs no dac.

Feature	CJC-1295 with DAC	CJC-1295 no DAC (Mod GRF 1-29)
Half-life	About 6-8 days	About 30 minutes
Albumin binding	Yes	No
Growth hormone pattern	Sustained elevation	Short, pulsatile release
Typical research frequency	Once weekly or less	1-3 times daily
Common vial sizes	2mg, 5mg	2mg, 5mg, 10mg
Relative cost per mg	Usually higher	Usually lower

The two forms are not interchangeable in a protocol, because switching between them changes the shape of the growth hormone pulse entirely.

CJC-1295 No DAC Dosage in Research and Community Discussion

There is no FDA-approved dose and no established human dosing schedule. What circulates online as "cjc-1295 no dac dosage" is a mix of rodent-model extrapolation and self-reported user logs, so every number should be treated as unverified.

The figures repeated most often in community write-ups include:

• 100 mcg injected once daily as a starting reference point
• 100-200 mcg per injection, one to three times per day
• Doses timed before sleep to align with natural nocturnal GH release
• Cycle lengths of roughly 8-12 weeks, often followed by a break

Some sources quote 1-2 mcg per kilogram of body weight, but that scaling comes from animal work and does not translate cleanly to humans.

Stacking With a GHRP Like Ipamorelin

CJC-1295 no DAC is frequently paired with a ghrelin-receptor agonist such as ipamorelin because the two act through different pathways. Traffic around cjc 1295 no dac ipamorelin reddit reflects how common that pairing has become in anecdotal reports.

A related search phrasing is cjc-1295 ipamorelin dac or no dac, and most community protocols favor the no-DAC form for its shorter, more physiologic pulse. These routines are self-reported, not clinical guidance, and no controlled human trial supports them.

Storage, Reconstitution, and Handling

Peptide integrity depends heavily on how the vial is stored and mixed. A 2mg lyophilized vial is stable for months when handled correctly.

• Store lyophilized vials at -20°C or in a freezer for long-term stability
• Keep the powder away from light; amber or opaque packaging matters
• Reconstitute with bacteriostatic water, adding it slowly down the vial wall
• Swirl gently instead of shaking, since foaming can damage the peptide
• Store the reconstituted solution at 2-8°C and use it within about 4-6 weeks
• Avoid repeated freeze-thaw cycles

Safety, Legal Status, and Sourcing

CJC-1295 is not FDA-approved for human use in the United States. It is legally sold only as a research chemical for in vitro and animal study, and products labeled "for research use only" are not intended for human consumption.

Side effects reported in anecdotal accounts include injection-site irritation, flushing, headache, and fluid retention. Long-term human safety data do not exist, and the peptide sits on the WADA prohibited list.

Anyone considering a GHRH analog for personal use should speak with a licensed healthcare professional rather than relying on forum posts.

Because the research-chemical market is largely unregulated, purity varies widely between vendors. Third-party certificates of analysis, mass spectrometry data, and HPLC results are the minimum evidence to look for before buying any 2mg vial.

Bottom Line on CJC-1295 No DAC 2mg

CJC-1295 no DAC 2mg is a short-acting GHRH analog that produces a brief, pulsatile growth hormone signal rather than the sustained elevation seen with the DAC version.

The 2mg vial is a standard research size, and it is the no-DAC form, not the DAC form, that most community protocols stack with ipamorelin.

CJC-1295 is not FDA-approved for human use in the United States and is sold legally only as a research chemical.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical CJC-1295 no DAC dosage?

No FDA-approved human dose exists. Community logs usually cite 100-200 mcg per injection, one to three times daily, but those numbers come from self-reporting and rodent-model extrapolation rather than controlled human trials. Any dosing decision should be discussed with a licensed healthcare professional.

What is the difference between CJC-1295 with DAC and without DAC?

The DAC version binds to serum albumin, which extends its half-life to roughly 6-8 days and produces sustained growth hormone elevation. The no-DAC version, also called mod GRF 1-29, has a half-life of about 30 minutes and creates a short, pulsatile release. Neither form is FDA-approved for human use.

Is CJC-1295 no DAC legal to buy in the US?

It is not FDA-approved as a drug, so it is sold only as a research chemical for laboratory use. Buying it for personal human consumption falls outside that intended use, and the peptide is banned by WADA for athletes. Consult a healthcare provider before using any research peptide.